Evidence map›Paper›PMID 35092032›Full record

ArticleEuropean journal of immunology2022

A population of naive-like CD4

Jonathan W Lo, Maria Vila de Mucha, Stephen Henderson, Luke B Roberts, Laura E Constable, Natividad Garrido-Mesa, Arnulf Hertweck, Emilie Stolarczyk, Emma L Houlder, Ian Jackson and 6 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Jonathan W LoSchool of Immunology and Microbial Sciences, King's College London, London, UK.ORCID 0000-0002-2514-9333
Maria Vila de MuchaUCL Cancer Institute and CRUK UCL Centre, University College London (UCL), London, UK.
Stephen HendersonUCL Cancer Institute and CRUK UCL Centre, University College London (UCL), London, UK.
Luke B RobertsSchool of Immunology and Microbial Sciences, King's College London, London, UK.
Laura E ConstableSchool of Immunology and Microbial Sciences, King's College London, London, UK.
Natividad Garrido-MesaSchool of Immunology and Microbial Sciences, King's College London, London, UK.
Arnulf HertweckUCL Cancer Institute and CRUK UCL Centre, University College London (UCL), London, UK.
Emilie StolarczykAbcam Plc., Cambridge Biomedical Campus, Cambridge, UK.
Emma L HoulderLydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Ian JacksonSchool of Immunology and Microbial Sciences, King's College London, London, UK.
Andrew S MacDonaldLydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Nick PowellSchool of Immunology and Microbial Sciences, King's College London, London, UK.
Joana F NevesSchool of Immunology and Microbial Sciences, King's College London, London, UK.
Jane K HowardSchool of Cardiovascular Medicine and Sciences, Guy's Campus, King's College London, London, UK.
Richard G JennerUCL Cancer Institute and CRUK UCL Centre, University College London (UCL), London, UK.
Graham M LordSchool of Immunology and Microbial Sciences, King's College London, London, UK.
King's College London · GBCRUK Lung Cancer Centre of Excellence · GBUniversity of Manchester · GBAbcam (United States) · US

Funding

Cancer Research UK C416/A25145Department of HealthMedical Research Council MC_PC_14105Medical Research Council MR/K002996/1Medical Research Council MR/M003493/1Medical Research Council MR/R001413/1Medical Research Council MR/R024812/1Medical Research Council MR/W002337/1Medical Research Council MR/W018748/1Wellcome TrustWellcome Trust WT101159
6 · The paper itself

Abstract

T-bet is the lineage-specifying transcription factor for CD4

Indexed as

T-Box Domain ProteinsTh1 CellsAnimalsCell DifferentiationGene Expression RegulationLymphocyte ActivationMiceTh17 CellsTh2 CellsT-Lymphocytes, RegulatoryT-Box Domain ProteinsCD4 T cellscolitisGene regulationIFNgImmune regulationmouse modelnaive T cellsT-betT cellsTH1T helper cellsTransgenic models

Identifiers

PMID35092032
PMCPMC9304323
OpenAlexW4210300067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.